Group

N

Pre-treatment

After 12 weeks of treatment

Zoledronic acid

56

3.982 ± 1.0701

2.143 ± 0.9031

Denosumab

48

4.104 ± 1.0156

1.417 ± 0.7390

t

0.593

−4.44

P

0.554

0.000023